Pecam-1 modulation
CA 2470696 A1 · Owner: Cicmil, Milenko · Inventors: Cicmil, Milenko; Gibbins, Jonathan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Activation of PECAM-1 (platelet endothelial cell adhesion molecule-1) with for example a small molecule or antibody derivative provides a new therapeutic route for modifying platelet activation and thrombus formation which has utility in the treatment or prevention of cardiovascular diseases such as , thrombosis, stroke and vascular occlusion and in the treatment or prevention of homeostasis disorders. This gives a better approach to the treatment of these conditions than existing drugs as it activates a general inhibitory mechanism rather than merely blocking one arm of the activation system. A screen for activators of PECAM-1 comprises PECAM-1 an ectodomain of PECAM-1, the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 17, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 17, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 17, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.